DALLAS, May 01, 2018 -- Via OTC PR Wire – Puration, Inc. (USOTC:PURA) Today announced plans to produce a THC infused beverage in Canada in conjunction with a previously announced pending acquisition intended to establish a cannabis cultivation operation for the recreational marijuana market expected to be legalized nationwide in Canada this summer. The new THC infused beverage will expand Puration’s current cannabis infused beverage business. Last year, Puration introduced EVERx, a CBD infused sports water. The sales of EVERx yielded over a 60% gross margin as reported in the company’s 2017 annual report. The initial sales have won the interest of additional distributors to include a recently announced national distribution contract. Puration has designed a THC infused beverage and registered the name THCSavor. Package design is underway. Highlights of the THCSavor go-to-market plan are to be included in the upcoming shareholder presentation scheduled for, Thursday next week, on May 10th, to provide overall details on the Canadian business acquisition expected to be closed as early as the end of this week.
For more information on Puration, visit http://www.aciconglomerated.com.
Disclaimer/Safe Harbor:
This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
Puration, Inc.
Brian Shibley,
[email protected]
+1-800-861-1350


Toyota First-Half Global Sales and Production Decline on Weak China Demand, RAV4 Transition
Holcim Raises 2026 Outlook After Strong Q2 Earnings Beat
Starbucks Stock Jumps as Q3 Earnings Beat, Sales Growth Drives Higher 2026 Outlook
Russia Charges Telegram Founder Pavel Durov With Facilitating Terrorism, Seeks International Arrest
Meta Stock Drops After Earnings Miss as AI Spending and Legal Costs Weigh on Profit
Sony Eyes $1.3 Billion Tamron Acquisition as Lens Maker Reviews Offer
Apple Q3 Earnings Beat as Record iPhone Sales Offset Services, China Weakness
Robinhood Q2 Earnings Beat Estimates, But HOOD Stock Falls as Investors Question Profit Quality
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline
SpaceX Wins $1.6 Billion U.S. Space Force Launch Contracts for Falcon 9 Missions Through 2027
Amazon Q2 Earnings Beat Estimates as AWS AI Growth Surges, But Q3 Revenue Forecast Disappoints
Arm Holdings Q1 Earnings Beat Estimates, Strong Q2 Outlook Fails to Lift ARM Stock
Colgate-Palmolive Reaffirms 2026 Sales Outlook Despite Weak North America Demand
Sony Raises Full-Year Outlook After Q1 Profit Jumps 40% on Gaming and Chip Growth
Qualcomm Stock Falls as Weak Q4 Forecast, Apple Revenue Decline Overshadow AI Data Center Growth
Tesla Weighs China Business Separation Amid SpaceX Merger Speculation
Apple Stock Slides 7% as Weak Sales Forecast Overshadows Quarterly Earnings Beat 



